课题基金 / 基金详情

Mechanisms of bone resorption in alveolar bone of IL-1 transgenic mice

Mechanisms of bone resorption in alveolar bone of IL-1 transgenic mice
IL-1转基因小鼠牙槽骨骨吸收机制
批准号:
15390564
负责人:
SHINKI Toshimasa
金额:
$8.38万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

SHINKI Toshimasa的其他基金

相似基金

相关文献

中文摘要
翻译
牙周病是一种感染性慢性炎症性疾病,可导致牙槽骨丢失和牙周区域结缔组织破坏。骨吸收是通过免疫反应触发的,并且是针对牙周病细菌的炎症反应的结果。破骨细胞是骨吸收细胞,从巨噬细胞/单核细胞谱系细胞分化而来,并被NF-κB配体受体激活剂(RANKL)激活。针对牙周病细菌的活化的抗原特异性CD 4阳性T细胞产生RANKL,RANKL已被证明在牙周病的骨吸收中起关键作用。RANKL表达于成骨细胞/基质细胞的细胞膜上,刺激破骨细胞生成。在本研究中,RANKL mRNA的表达水平在牙槽骨进行了检查。IL-1转基因小鼠牙槽骨RANKL mRNA表达水平与野生型小鼠无明显差异。相反,IL-1转基因小鼠股骨中RANKL mRNA表达显著增加。而牙槽骨骨密度不受IL-1过量产生的影响。这些结果表明,牙槽骨吸收是由不同的机制,发生在长骨的调节。
英文摘要
Periodontal diseases are infectious, chronic inflammatory diseases that result both in loss of alveolar bone and destruction of connective tissue in periodontal regions. The bone resorption is triggered through immune responses, and results from inflammatory reactions directed against periodontopathic bacteria. Osteoclasts, bone resorbing cells, differentiate from macrophage/monocyte lineage cells, and are activated by receptor activator of NF-κB ligand (RANKL). Activated antigen-specific CD4 positive T-cells directed against periodontopathic bacteria produce RANKL, which has been shown to play a critical role in bone resorption in periodontal diseases.RANKL, which is expressed on the cell membrane of osteoblasts/stromal cells, stimulates osteoclastogenesis. In the present study, the expression level of RANKL mRNA in alveolar bone was examined. The expression level of RANKL mRNA in alveolar bone in IL-1 transgenic mice was not different from wild one. In contrast, RANKL mRNA expression was significantly increased in the femur of IL-1 transgenic mice. However, bone mineral density of alveolar bone did not influence by the overproduction of IL-1. These results indicate that alveolar bone resorption was regulated by the different mechanisms which occurred in the long bone.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Takemoto, F., Shinki, T.et al.: "Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats."Kidney Int.. 64(2). 414-420 (2003)
Takemoto, F., Shinki, T.等人:“肾切除大鼠残肾中维生素 D 羟化酶和巨蛋白的基因表达。”Kidney Int.. 64(2)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ueno, Y., Shinki, T.et al.: "In vivo administration of 1,25-dihydroxyvitamin D_3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH."J.Cell.Biochem.. 90(2). 267-277 (2003)
Ueno, Y., Shinki, T.等人:“体内施用 1,25-二羟基维生素 D_3 可抑制持续输注 PTH 的甲状旁腺切除大鼠骨中 RANKL mRNA 的表达。”J.Cell.Biochem.. 90(
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1007/s11914-012-0098-z
发表时间: 2012-06
期刊: CURRENT OSTEOPOROSIS REPORTS
影响因子: 4.3
作者: [Bikle, Daniel D.]
通讯作者: Bikle, Daniel D.
DOI: 10.1096/fj.02-0965fje
发表时间: 2003-02-01
期刊: FASEB JOURNAL
影响因子: 4.8
作者: [Hosogane, N, Shinki, T, Suda, T]
通讯作者: Suda, T
共 12 条
    Evidence base treatment of renal osteodistropy
    • 批准号:
      17590066
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2005
    • 负责人:
      SHINKI Toshimasa
    • 依托单位:
    Role of Vitamin D hydroxylase on Bone Metabolism.
    • 批准号:
      12470392
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.41万
    • 财政年份:
      2000
    • 负责人:
      SHINKI Toshimasa
    • 依托单位:
    Mechanism of regulation of vitamin D metabolism at molecular level.
    • 批准号:
      08457494
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.93万
    • 财政年份:
      1996
    • 负责人:
      SHINKI Toshimasa
    • 依托单位:
    Role of vitamin D and parathyroid hormone on vitamin D metabolism in the kidney.
    • 批准号:
      06454527
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.48万
    • 财政年份:
      1994
    • 负责人:
      SHINKI Toshimasa
    • 依托单位:
    海外基金